<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-pharmaceuticals-13-00096">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cao</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wen</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Fan</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Ruan</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Cai</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1056/NEJMoa2001282</pub-id>
 </element-citation>
</ref>
